APA (7th ed.) Citation

Chong, H. Y., Lim, Y. H., Prawjaeng, J., Tassaneeyakul, W., Mohamed, Z., & Chaiyakunapruk, N. (2017). Cost-effectiveness analysis of HLA-B*58: 01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population. Lippincott, Williams & Wilkins.

Chicago Style (17th ed.) Citation

Chong, Huey Yi, Yi Heng Lim, Juthamas Prawjaeng, Wichittra Tassaneeyakul, Zahurin Mohamed, and Nathorn Chaiyakunapruk. Cost-effectiveness Analysis of HLA-B*58: 01 Genetic Testing Before Initiation of Allopurinol Therapy to Prevent Allopurinol-induced Stevens-Johnson Syndrome/toxic Epidermal Necrolysis in a Malaysian Population. Lippincott, Williams & Wilkins, 2017.

MLA (9th ed.) Citation

Chong, Huey Yi, et al. Cost-effectiveness Analysis of HLA-B*58: 01 Genetic Testing Before Initiation of Allopurinol Therapy to Prevent Allopurinol-induced Stevens-Johnson Syndrome/toxic Epidermal Necrolysis in a Malaysian Population. Lippincott, Williams & Wilkins, 2017.